EUVIMEDEUVIMED entdecken
Crossref

Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials

Eleonora Nicolò, Sara Gandini, Federica Giugliano, Jacopo Uliano, Oriana D'Ecclesiis, Stefania Morganti, Emanuela Ferraro, Dario Trapani, Paolo Tarantino, Paola Zagami, Laura Boldrini, Irene Caramella und 9 weitere

European Journal of Cancer · 2024

DOI: 10.1016/j.ejca.2024.114181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Eleonora Nicolò und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncolog…. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsHumansFemaleMaleAgedMiddle AgedRetrospective StudiesAge FactorsAdultAged, 80 and overClinical Trials, Phase I as TopicClinical Trials, Phase II as TopicYoung AdultTreatment Outcome

Stichwörter der Autor:innen

Adverse eventsAgeCancerEarly-phase clinical trialElderlyOutcomePhase ISafetySolid tumorsSurvival

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy; Department…
  • Molecular and Pharmaco-Epidemiology Unit, Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.
  • Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Zitieren

APA

Nicolò, E., Gandini, S., Giugliano, F., Uliano, J., D'Ecclesiis, O., Morganti, S., Ferraro, E., Trapani, D., Tarantino, P., Zagami, P., Boldrini, L., Caramella, I., Carnevale Schianca, A., Cristofanilli, M., Locatelli, M. A., Esposito, A., Belli, C., Minchella, I., Criscitiello, C., …, & Curigliano, G. (2024). Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.114181

Vancouver

Nicolò E, Gandini S, Giugliano F, Uliano J, D'Ecclesiis O, Morganti S, et al. Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.114181

BibTeX
@article{Nicol2024,
  author = {Nicolò, Eleonora and Gandini, Sara and Giugliano, Federica and Uliano, Jacopo and D'Ecclesiis, Oriana and Morganti, Stefania and Ferraro, Emanuela and Trapani, Dario and Tarantino, Paolo and Zagami, Paola and Boldrini, Laura and Caramella, Irene and Carnevale Schianca, Ambra and Cristofanilli, Massimo and Locatelli, Marzia Adelia and Esposito, Angela and Belli, Carmen and Minchella, Ida and Criscitiello, Carmen and Marra, Antonio and Curigliano, Giuseppe},
  title = {Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials},
  journal = {European Journal of Cancer},
  year = {2024},
  doi = {10.1016/j.ejca.2024.114181}
}
Kostenlos starten →